Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Shares | 96.290 | 96.290 | 0.000 |
Bonds | 0.060 | 0.060 | 0.000 |
Convertible | 0.140 | 0.140 | 0.000 |
Preferred | 3.410 | 3.410 | 0.000 |
Other | 0.140 | 0.250 | 0.110 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 21.654 | 28.061 |
Price to Book | 4.819 | 5.545 |
Price to Sales | 1.975 | 5.590 |
Price to Cash Flow | 18.300 | 20.937 |
Dividend Yield | 0.765 | 0.569 |
5 Years Earnings Growth | 11.967 | 13.968 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 99.550 | 59.217 |
Basic Materials | 0.400 | 0.400 |
Industrials | 0.050 | 0.426 |
Number of long holdings: 269
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
UnitedHealth | US91324P1021 | 8.25 | 497.12 | -0.04% | |
Eli Lilly | US5324571083 | 8.24 | 878.45 | -0.55% | |
Thermo Fisher Scientific | US8835561023 | 4.79 | 572.05 | -0.03% | |
Intuitive Surgical | US46120E6023 | 3.90 | 425.78 | +0.68% | |
Elevance Health | US0367521038 | 3.60 | 534.81 | -0.73% | |
Merck&Co | US58933Y1055 | 3.55 | 129.48 | +0.09% | |
Stryker | US8636671013 | 3.37 | 344.98 | +0.57% | |
Danaher | US2358511028 | 2.88 | 254.85 | -0.06% | |
Vertex | US92532F1003 | 2.79 | 480.73 | +0.35% | |
AstraZeneca ADR | US0463531089 | 2.02 | 79.59 | +0.08% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
TD Dividend Growth Fund D-Series | 9.84B | 6.73 | 8.15 | - | ||
TD Dividend Growth I | 9.84B | 6.28 | 7.07 | 6.65 | ||
TD Dividend Growth F | 9.84B | 6.81 | 8.31 | 7.87 | ||
TD Dividend Growth S | 9.84B | 6.80 | 8.49 | 7.92 | ||
TD Dividend Growth Fund Premium F | 9.84B | 6.82 | 8.35 | 7.94 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review